PTC THERAPEUTICS, INC. 4
4 · PTC THERAPEUTICS, INC. · Filed Jan 5, 2017
Insider Transaction Report
Form 4
Rothera Mark
Chief Commercial Officer
Transactions
- Award
Common Stock
2017-01-03+9,600→ 22,523 total - Award
Stock Option (Right To Buy)
2017-01-03+56,000→ 56,000 totalExercise: $11.23Exp: 2027-01-02→ Common Stock (56,000 underlying)
Footnotes (3)
- [F1]Restricted stock awarded to the Reporting Person vests in four equal annual installments over four years, commencing on January 3, 2018.
- [F2]Includes 1,707 shares acquired under the Issuer's employee stock purchase plan for the period ending December 31, 2016.
- [F3]This option was granted on January 3, 2017, and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2018, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2018.